The state-run Indian Council of Medical Research (ICMR) and privately-held Bharat Biotech this month started third-stage trials of COVAXIN, in a process that would involve 26,000 volunteers. It is the most advanced Indian experimental vaccine. He reiterated the government's plan was to immunize 200 million to 250 million Indians by July. Also Read - US approves Covid-19 therapy, G20 pushes for global vaccine accessVardhan, however, said in September the government could opt for emergency vaccine authorization, particularly for the elderly and people in high-risk workplaces. India on Sunday recorded 45,209 new infections, taking the total to 9.09 million, only behind that of the United States.

Source: Dhaka Tribune November 22, 2020 17:03 UTC